MCP-5 Activators
MCP-5 Activators are a set of chemical compounds that indirectly amplify the activity of MCP-5 by modulating various signaling molecules and pathways that MCP-5 is directly involved in. Compounds such as Forskolin, Prostaglandin E2 (PGE2), and Butaprost work by increasing intracellular levels of cAMP, which in turn activates PKA. The activation of PKA can lead to phosphorylation events that bolster MCP-5 signaling pathways, enhancing the protein's functional activity. Similarly, EP receptor agonists like Misoprostol and Iloprost, by raising cAMP levels, indirectly potentiate MCP-5 activity. The naturally occurring Prostacyclin (PGI2) also raises cAMP, suggesting a potential to amplify MCP-5-related signaling. Another mechanism involves the inhibition of cAMP breakdown; Rolipram, as a PDE4 inhibitor, prevents the degradation of cAMP, consequently promoting PKA signaling and MCP-5 activity.
The activity of MCP-5 is further influenced by modulators of adrenergic signaling. Terbutaline and Salbutamol, both β2-adrenergic agonists, and Isoproterenol, a non-selective β-adrenergic agonist, lead to increased cAMP production, which could activate PKA and enhance MCP-5 signaling. Sildenafil, by inhibiting PDE5, elevates both cAMP and cGMP levels, which may indirectly augment MCP-5 activity through PKA and PKG pathways. Lastly, Epinephrine, with its broad receptor affinity, stimulates the production of cAMP, supporting enhanced MCP-5 activity via PKA-dependent signaling. Collectively, these MCP-5 Activators facilitate the indirect enhancement of MCP-5 activity by modulating signaling pathways that lead to phosphorylation and activation events within the cellular environment where MCP-5 is functionally relevant.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates intracellular cAMP levels, leading to the activation of protein kinase A (PKA). PKA can phosphorylate substrates relevant to the signaling pathways that MCP-5 is involved in, thereby increasing MCP-5 activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Binds to its receptors (EP receptors), leading to increased cAMP production, which can subsequently activate PKA and potentially enhance MCP-5 activity through downstream signaling effects. | ||||||
Butaprost | 69685-22-9 | sc-221387 sc-221387A | 500 µg 1 mg | $126.00 $242.00 | 1 | |
A selective EP2 receptor agonist that increases intracellular cAMP, which could lead to the activation of signaling pathways involving MCP-5. | ||||||
Misoprostol | 59122-46-2 | sc-201264 sc-201264A sc-201264B | 10 mg 100 mg 1 g | $183.00 $1149.00 $7080.00 | 2 | |
An EP4 receptor agonist that increases cAMP in target cells and may result in amplified signaling through pathways where MCP-5 is active. | ||||||
Iloprost | 78919-13-8 | sc-205349 sc-205349A | 500 µg 1 mg | $155.00 $269.00 | ||
Activates IP receptors leading to increased cAMP levels, which could enhance signaling mechanisms that contribute to MCP-5 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
A selective PDE4 inhibitor that prevents cAMP breakdown, potentially enhancing PKA-mediated signaling pathways involving MCP-5. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Another β2-adrenergic agonist that promotes cAMP synthesis and could lead to the activation of MCP-5 through PKA signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A non-selective β-adrenergic agonist that elevates cAMP and could indirectly enhance MCP-5 activity via PKA-dependent pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Stimulates both α and β-adrenergic receptors leading to increased cAMP, which may bolster MCP-5 activity through PKA signaling. | ||||||